Skip to content
Screener

Similar metrics at other companies

Interface logo
TILEAMS — D&A
$4.8M+4.7%
Team logo
TISIMS — D&A
$3.71M-13.3%
JB Hunt Transport Services logo
JBHTFMS — D&A
$11M0.0%
MYR Group logo
MYRGT&D — D&A
$15.92M+11.7%
Taboola.com Ltd. logo
TBLAD&A
$7.31M-21.7%
Brink's, Inc. logo
BCOD&A
$79.1M+32.3%

Other financials

Income statement

See full
Revenue$1.0B-2.7%
Gross profit$349.0M-3.5%
Operating income$119.9M+19.7%
Net income-$1.5M-103%
EPS (diluted)-$0.03-103%

Balance sheet

See full
Cash & equivalents$240.6M+30.2%
Total debt$3.0B+8.1%
Total equity$2.8B-15.3%
Total assets$7.5B-0.4%

Cash flow

See full
Operating cash flow$179.7M-12.2%
CapEx$31.1M-11.9%
Free cash flow$148.6M-12.2%

Valuation

See full
Market cap$12.68B+71.7%
Enterprise value$15.48B+54.6%
P/S3.2×+1.3×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-6%
FCF margin9.3%-5.1pp

Returns & leverage

See full
Return on equity-7.7%
Debt / equity1.1×+0.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 9:21 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001100682-26-000118
Line itemSix Months Ended / June 27, 2026Six Months Ended / June 28, 2025
Cash flows relating to operating activities
Net income (loss)$(15,562)$78,571
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization134,441239,871
Long-lived asset impairments26,27931,203
Stock-based compensation42,16230,184
Deferred income taxes12,077(41,030)
Write down of inventories3,16511,067

Item 1. Financial Statements

FAQ

What is Charles River Laboratories's RMS — D&A?
Charles River Laboratories (CRL) reported RMS — D&A of $15.73M in Q2 2026.
How has Charles River Laboratories's RMS — D&A changed year-over-year?
Charles River Laboratories's RMS — D&A decreased by 20.2% year-over-year, from $19.71M to $15.73M.
What is the long-term trend for Charles River Laboratories's RMS — D&A?
Over 2 years (2023 to 2025), Charles River Laboratories's RMS — D&A has grown at a 20.8% compound annual growth rate (CAGR), from $55.57M to $81.08M.
What does RMS — D&A mean?
The total non-cash expense representing the allocation of the cost of tangible and intangible assets over their useful lives within the Research Models and Services segment. This metric accounts for the wear and tear of physical assets and the expiration of intangible assets. It is a key component in reconciling net income to cash flow from operations.

Ask your AI about Charles River Laboratories's rms — d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude